Is the end of gonorrhoea in sight?

Affiliations

¹ Central Clinical School, Monash University, Melbourne, VIC, Australia; Melbourne Sexual Health Centre, Alfred Health, Melbourne, VIC, Australia. Electronic address: jason.ong@monash.edu.
² WHO Collaborating Centre for Gonorrhoea and other STIs, Örebro University, Örebro, Sweden; Institute for Global Health, University College London, London, UK.
³ Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne, Melbourne, VIC, Australia.
⁴ Central Clinical School, Monash University, Melbourne, VIC, Australia; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, VIC, Australia.

Comment

Jason J Ong et al. Lancet Infect Dis. 2022 Jul.

. 2022 Jul;22(7):919-921.

doi: 10.1016/S1473-3099(22)00002-0. Epub 2022 Apr 12.

¹ Central Clinical School, Monash University, Melbourne, VIC, Australia; Melbourne Sexual Health Centre, Alfred Health, Melbourne, VIC, Australia. Electronic address: jason.ong@monash.edu.
² WHO Collaborating Centre for Gonorrhoea and other STIs, Örebro University, Örebro, Sweden; Institute for Global Health, University College London, London, UK.
³ Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne, Melbourne, VIC, Australia.
⁴ Central Clinical School, Monash University, Melbourne, VIC, Australia; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, VIC, Australia.

No abstract available

Comment on

Effectiveness of a serogroup B outer membrane vesicle meningococcal vaccine against gonorrhoea: a retrospective observational study.
Abara WE, Bernstein KT, Lewis FMT, Schillinger JA, Feemster K, Pathela P, Hariri S, Islam A, Eberhart M, Cheng I, Ternier A, Slutsker JS, Mbaeyi S, Madera R, Kirkcaldy RD. Abara WE, et al. Lancet Infect Dis. 2022 Jul;22(7):1021-1029. doi: 10.1016/S1473-3099(21)00812-4. Epub 2022 Apr 12. Lancet Infect Dis. 2022. PMID: 35427490 Free PMC article.
Effectiveness and impact of the 4CMenB vaccine against invasive serogroup B meningococcal disease and gonorrhoea in an infant, child, and adolescent programme: an observational cohort and case-control study.
Wang B, Giles L, Andraweera P, McMillan M, Almond S, Beazley R, Mitchell J, Lally N, Ahoure M, Denehy E, Koehler A, Flood L, Marshall H. Wang B, et al. Lancet Infect Dis. 2022 Jul;22(7):1011-1020. doi: 10.1016/S1473-3099(21)00754-4. Epub 2022 Apr 12. Lancet Infect Dis. 2022. PMID: 35427492